首页|99Tcm-HYNIC-PSMA SPECT/CT在前列腺癌生化复发中的临床价值

99Tcm-HYNIC-PSMA SPECT/CT在前列腺癌生化复发中的临床价值

Clinical value of 99Tcm-HYNIC-PSMA SPECT/CT in biochemical recurrence of prostate cancer

扫码查看
目的 探讨99Tcm-联肼尼克酰胺(HYNIC)-前列腺特异膜抗原(PSMA)SPECT/CT显像在前列腺癌(PCa)生化复发中的价值.方法 回顾性分析2018年1月至2023年3月间于河南省人民医院行99Tcm-HYNIC-PSMA SPECT/CT显像且资料完整的112例PCa生化复发患者[年龄(72.6± 6.1)岁].根据前列腺特异抗原(PSA)水平分为0.2 μg/L<PSA≤1 µg/L组、1 μg/L<PSA≤2 μg/L组和PSA>2 µg/L组;根据Gleason评分分为Gleason评分≥8分组和Gleason评分<8分组.采用x2检验比较组间检出率,采用Mann-WhitneyU检验比较组间PSA水平差异.结果 PSMA显像阳性77例,阴性35例,检出率68.8%(77/112).局部复发、淋巴结转移、骨转移、肺转移的检出率分别为8.9%(10/112)、43.8%(49/112)、28.6%(32/112)、0.9%(1/112).0.2 μg/L<PSA≤1 μg/L 组(n=47)、1 μg/L<PSA≤2 μg/L组(n=12)和PSA>2 μg/L组(n=53)的检出率分别为44.7%(21/47)、8/12、90.6%(48/53),差异有统计学意义(x2=24.44,P<0.001).Gleason评分≥8分组(n=72)、Gleason评分<8分组(n=40)的检出率分别为 76.4%(55/72)、55.0%(22/40),差异有统计学意义(x2=5.47,P=0.032);Gleason 评分≥8 分组的 PSA 水平高于 Gleason 评分<8 分组[3.11(0.75,5.91)和 0.84(0.44,2.92)μg/L;z=-2.99,P=0.003].PSMA显像阳性患者中,84.4%(65/77)患者更改治疗方案;15.6%(12/77)患者继续观察或维持原治疗方案.PSMA显像阴性患者中,40.0%(14/35)患者更换治疗方案;51.4%(18/35)患者继续观察或维持原治疗方案;8.6%(3/35)患者因检查未发现肿瘤转移灶而暂停原治疗方案.结论 99Tcm-HYNIC-PSMA SPECT/CT显像结果可为PCa生化复发病灶探测、诊疗决策和随访观察提供参考依据.
Objective To investigate the value of 99Tcm-hydrazinonicotinamide(HYNIC)-prostate specific membrane antigen(PSMA)SPECT/CT imaging in biochemical recurrence of prostate cancer(PCa).Methods From January 2018 to March 2023,112 patients with biochemical recurrence of PCa(age(72.6±6.1)years)who underwent 99Tcm-HYNIC-PSMA SPECT/CT imaging in Henan Provincial People's Hospital were retrospectively analyzed.According to the level of prostate specific antigen(PSA),patients were divided into 0.2 pg/L<PSA≤1 pg/L group,1 pg/L<PSA≤2 μg/L group,and PSA>2 μg/L group.According to the Gleason score,patients were divided into Gleason score≥8 group and Gleason score<8 group.The detection rate between groups was analyzed by x2 test,and the difference of the PSA level be-tween groups was compared by Mann-Whitney U test.Results PSMA imaging was positive in 77 cases and negative in 35 cases,with the detection rate of 68.8%(77/112).The detection rates of local recurrence,lymph node metastasis,bone metastasis and lung metastasis were 8.9%(10/112),43.8%(49/112),28.6%(32/112)and 0.9%(1/112),respectively.The detection rates of 0.2 μg/L<PSA≤1 μg/L,1 µg/L<PSA≤2 μg/L and PSA>2 μg/L groups were 44.7%(21/47),8/12 and 90.6%(48/53),respectively(x2=24.44,P<0.001).The detection rates of Gleason score ≥8 group and<8 group were 76.4%(55/72)and 55.0%(22/40)(x2=5.47,P=0.032);the PSA level between the two groups was statistically different(3.11(0.75,5.91)and 0.84(0.44,2.92)μg/L;z=-2.99,P=0.003).Of the patients with PSMA posi-tive imaging,84.4%(65/77)changed their treatment regimen and 15.6%(12/77)continued to observe or maintain the original treatment plan.Of the patients with PSMA negative imaging,40.0%(14/35)changed the treatment plan,51.4%(18/35)continued to observe or maintain the original treatment plan,and 8.6%(3/35)discontinued the original treatment because no tumor metastasis was found.Conclusion 99 Tcm-HYNIC-PSMA SPECT/CT imaging can provide reference for the lesion detection,treatment decision-making and follow-up observation of biochemical recurrence of PCa.

Prostatic neoplasmsNeoplasm recurrence,localProstate-specific membrane anti-genTomography,Emission-computed,single-photonTomography,X-ray computed

赵尊、武新宇、李博、白鑫、施婧琦、刘斯淼、徐俊玲、高永举

展开 >

郑州大学人民医院、河南省人民医院核医学科

河南省核医学新型分子探针与临床转化医学重点实验室,郑州 450003

前列腺肿瘤 肿瘤复发,局部 前列腺特异膜抗原 体层摄影术,发射型计算机,单光子 体层摄影术,X线计算机

河南省医学科技攻关省部共建重点项目

SBGJ202102015

2024

中华核医学与分子影像杂志
中华医学会

中华核医学与分子影像杂志

CSTPCD北大核心
影响因子:1.107
ISSN:2095-2848
年,卷(期):2024.44(4)
  • 17